41.57
-0.53 (-1.26%)
-0.53 (-1.26%)
Upgrade to Real-Time
Afterhours (Closed)
Best deals to access real time data! |
Big Cap Pro
Monthly Subscription
for only
|
Real-Time Alerts for Volume Breakouts, Highs and Lows for NYSE, NASDAQ, Amex, OTC Markets and OTCBB
Monthly Subscription
for only
|
Level 1 Starter
Monthly Subscription
for only
|
VAT not included
|
Company Name | Stock Ticker Symbol | Market | Type |
---|---|---|---|
Cassava Sciences Inc | SAVA | NASDAQ | Common Stock |
Price Change | Change Percent | Stock Price | Last Traded ![]() |
|
---|---|---|---|---|
-0.53 | -1.26% | 41.57 | 19:44:58 |
Open Price | Low Price | High Price | Close Price | Prev Close |
---|---|---|---|---|
41.69 | 40.80 | 42.27 | 41.57 | 42.10 |
Bid Price | Ask Price | Spread | News | |
---|---|---|---|---|
41.25 | 41.57 | 0.32 | - | - |
Trades | Volume | VWAP | Dollar Volume | Avg Volume | 52 Week Range |
---|---|---|---|---|---|
8,998 | 597,427 | $ 41.42 | $ 24,747,768 | 2,693,419 | 1.11 - 117.54 |
Last Trade Time | Type | Quantity | Stock Price | Currency |
---|---|---|---|---|
19:59:42 | 1 | $ 41.57 | USD |
Cassava Sciences Financials
Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
---|---|---|---|---|---|---|
$ 1.45B | 34.95M | 33.13M | $ - | $ - | -0.27 | -51.50 |
Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
---|---|---|---|---|---|
- | $ - | 0.00% | - | - |
Cassava Sciences News
Date | Time | Source | News Article |
---|---|---|---|
3/31/2021 | 16:26 | Edgar (US Regulatory) | Proxy Statement (definitive) (def 14a) |
3/23/2021 | 17:06 | Edgar (US Regulatory) | Annual Report (10-k) |
3/23/2021 | 09:28 | Seeking Alpha | Cassava Sciences EPS misses by $0.04 |
3/23/2021 | 08:55 | Edgar (US Regulatory) | Current Report Filing (8-k) |
3/23/2021 | 08:30 | GlobeNewswire Inc. | Cassava Sciences Announces Full-year 2020 Financial Results.. |
3/19/2021 | 20:34 | TipRanks | Cassava: A Promising Yet Risky Alzheimer’s Pure Play |
3/18/2021 | 16:07 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) |
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical SAVA Price Data
Period | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
---|---|---|---|---|---|---|---|
1 Week | 47.45 | 47.68 | 40.35 | 42.72 | 987,791 | -5.88 | -12.39% |
1 Month | 52.44 | 63.65 | 40.35 | 53.10 | 2,015,011 | -10.87 | -20.73% |
3 Months | 10.38 | 117.54 | 9.9801 | 55.06 | 7,127,591 | 31.19 | 300.48% |
6 Months | 12.16 | 117.54 | 6.70 | 39.90 | 4,837,626 | 29.41 | 241.86% |
1 Year | 4.83 | 117.54 | 1.11 | 21.61 | 5,238,719 | 36.74 | 760.66% |
3 Years | 1.21 | 117.54 | 1.00 | 18.06 | 3,313,463 | 40.36 | 3,335.54% |
5 Years | 1.21 | 117.54 | 1.00 | 18.06 | 3,313,463 | 40.36 | 3,335.54% |
Cassava Sciences Description
Cassava Sciences Inc is a clinical-stage biotechnology company engaged in developing a scientific approach for the treatment and detection of Alzheimer's disease. It is also developing an experimental biomarker diagnostic PTI-125 to detect Alzheimer's disease with the help of a blood test. |